PharmaForceIQ cut media spend 35% while raising HCP engagement 10% and market share 3%.
The brand needed to cut media spend while holding position in an indication with eight competing brands and a 25% share. PharmaForceIQ triggered personalised content from ICD-10 claims data across email, display, social, programmatic and EHR with AI-driven sequences. The page reports a 35% media spend reduction, 10% higher HCP engagement and a 3% share increase.
PharmaForceIQ is an AI-driven HCP engagement and omnichannel orchestration company that acquired Aktana, used by pharma brands for trigger-based launch and non-personal promotion
This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
Published by PharmaForceIQ on its own site — read the original case study on pharmaforceiq.com ↗
Related use cases
- 01PharmaForceIQ's AI omnichannel platform traced 97% of first-year new prescriptions to its triggers and engagements.
- 02PharmaForceIQ ran lab- and claims-triggered optichannel journeys that lifted new prescriptions 22% in 12 months.
- 03PharmaForceIQ used predictive targeting and trigger-based journeys to triple the year-one launch forecast.
- 04PharmaForceIQ's trigger-based platform doubled HCP engagement from 14% to 32% in six months.
- 05Day One used PharmaForceIQ optichannel marketing for a rare pediatric oncology launch with 60% of new prescribers attributed to it.
- 06PharmaForceIQ covered vacant territories with digital-only optichannel campaigns, lifting unique prescribers 41%.